Search Results

Brand names in category HIV:

Generic names in category HIV:

Full Drug List

List Drugs by First Letter

Click on a letter to get a list of drug names starting with that letter:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

List Drugs by Name

Enter all or part of the name of the drug you are looking for:

Contact Us

By phone, live chat, e-mail, or callback request with questions about drug availability.
New! Call our expanded customer support center toll-free at 1-866-978-4944, 7 AM - 9 PM EST Mon - Fri, 9 AM - 5 PM EST Sat - Sun.

Free Shipping!

Shipping is free regardless of destination. There are no dispensing fees, membership fees, or any other hidden fees. Orders are sent by Registered Air Mail. Delivery time to the USA is typically 10 business days after we have sent the order, though it can take longer.

FDA Drug News

MedWatch Safety Alert RSS Feed
FDA MedWatch Safety Alerts
http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/MedWatch/rss.xml
en-us
Wed, 01 Sep 2010 10:00:00 -0400
jay.wattenberg@fda.hhs.gov (Jay Wattenberg)
FDA MedWatch
http://www.fda.gov/ucm/groups/fdagov-public/documents/image/ucm052224.gif
http://www.fda.gov/Safety/MedWatch/default.htm
144
52
FDA MedWatch Safety Alerts

Tygacil (tigecycline): Label Change - Increased Mortality Risk
Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.
Wed, 01 Sep 2010 10:00:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224626.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224626.htm

Huber Needles: Recall - Risk of Coring
Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient’s lungs.
Thu, 26 Aug 2010 15:40:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224163.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224163.htm

Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens
Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices.
Thu, 26 Aug 2010 14:30:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224135.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224135.htm

TimeOut Capsules: Undeclared Drug Ingredient
Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil

Home | About Us | Contact Us | Shipping | Q&A | Shop All Drugs | Links | Affiliates
For customer support, please call 1-866-978-4944, 7 AM - 9 PM EST Mon - Fri, 9 AM - 5 PM EST Sat - Sun or fax us at 1-800-876-0247. © 2002-2005 DRX Pharmaceuticals Corporation. Use of this site constitutes acceptance of our Terms of Use.